Thus, MV assessment may solve the issue of spatial tumour heterogeneity and contribute to an accurate representation of the actual PD-L1 status of the whole tumour mass, since circulating TC-derived PD-L1+ MVs are representative of PD-L1+ TCs at any tumour location. The gene discussed is CD274; the disease is neoplasm.